Isolated elevation of IgA anti-β2glycoprotein I antibodies with manifestations of antiphospholipid syndrome

A case series of five patients

S. Kumar, E. Papalardo, P. Sunkureddi, S. Najam, Emilio Gonzalez, S. S. Pierangeli

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Current diagnostic classification criteria recommend elevated titres of anti-cardiolipin (aCL) and/or anti-β2GPI antibody by ELISA IgG or IgM and/or lupus anticoagulant (LA) to confirm antiphospholipid syndrome (APS). Although IgA aPL antibodies have been shown to be pathogenic in animal models of APS, their clinical significance has remained elusive. We report four cases of exclusive IgA anti-β2GPI antibody sero-positivity with concomitant clinical manifestations associated with APS. Four of the five patients were LA negative. 1) Thirty-eight-year-old African-American female with SLE presented with resolving digital ulcers. Serum IgA anti-β2GPI antibody titres were 118.5 SAU (normal range: 0-20 SAU). 2) Twenty-seven-year-old African-American woman with SLE was evaluated for recent onset of severe headaches, unresponsive to analgesics and anti-migraine medications. MRI of the brain revealed hyper-intensities in the white matter in the frontal lobes. Serum IgA anti-β2GPI antibody titres were 29.1 Standard A Units (SAU). 3) Thirty-two-year-old Hispanic female with history of two unexplained miscarriages and negative serologies for SLE. Serum IgA anti-β2GPI antibody titres were 102.0 SAU. 4) Twenty-five-year-old white female with history of recent unexplained miscarriage in the 11th week of gestation and associated complaints of numbness and tingling in her hands. Her IgA anti-β2GPI antibody titre was 62.0 SAU. 5) Twenty-five-year-old African-American woman with SLE, positive for anti-Ro antibodies with a history of ischemic fingers, a pregnancy loss and recent pregnancy complicated due to pre-eclampsia. Her LA was positive and her IgA anti-β2 GPI antibody titer was 186.0 SAU. This case series supports that elevated IgA anti-β2GPI antibody titres may identify additional patients who have clinical features of APS but who do not meet current diagnostic criteria.

Original languageEnglish (US)
Pages (from-to)1011-1014
Number of pages4
JournalLupus
Volume18
Issue number11
DOIs
StatePublished - 2009

Fingerprint

Antiphospholipid Syndrome
Anti-Idiotypic Antibodies
Immunoglobulin A
Antibodies
Lupus Coagulation Inhibitor
African Americans
Spontaneous Abortion
Pregnancy
Serum
Cardiolipins
Hypesthesia
anti-IgA
Frontal Lobe
Serology
Pre-Eclampsia
Migraine Disorders
Hispanic Americans
Fingers
Ulcer
Immunoglobulin M

Keywords

  • Antiphospholipid antibodies
  • Antiphospholipid syndrome
  • IgA anti-β2glycoprotein I antibodies

ASJC Scopus subject areas

  • Rheumatology

Cite this

Isolated elevation of IgA anti-β2glycoprotein I antibodies with manifestations of antiphospholipid syndrome : A case series of five patients. / Kumar, S.; Papalardo, E.; Sunkureddi, P.; Najam, S.; Gonzalez, Emilio; Pierangeli, S. S.

In: Lupus, Vol. 18, No. 11, 2009, p. 1011-1014.

Research output: Contribution to journalArticle

Kumar, S. ; Papalardo, E. ; Sunkureddi, P. ; Najam, S. ; Gonzalez, Emilio ; Pierangeli, S. S. / Isolated elevation of IgA anti-β2glycoprotein I antibodies with manifestations of antiphospholipid syndrome : A case series of five patients. In: Lupus. 2009 ; Vol. 18, No. 11. pp. 1011-1014.
@article{157c9a821eb54f5bb0c3fc61e6a9d07a,
title = "Isolated elevation of IgA anti-β2glycoprotein I antibodies with manifestations of antiphospholipid syndrome: A case series of five patients",
abstract = "Current diagnostic classification criteria recommend elevated titres of anti-cardiolipin (aCL) and/or anti-β2GPI antibody by ELISA IgG or IgM and/or lupus anticoagulant (LA) to confirm antiphospholipid syndrome (APS). Although IgA aPL antibodies have been shown to be pathogenic in animal models of APS, their clinical significance has remained elusive. We report four cases of exclusive IgA anti-β2GPI antibody sero-positivity with concomitant clinical manifestations associated with APS. Four of the five patients were LA negative. 1) Thirty-eight-year-old African-American female with SLE presented with resolving digital ulcers. Serum IgA anti-β2GPI antibody titres were 118.5 SAU (normal range: 0-20 SAU). 2) Twenty-seven-year-old African-American woman with SLE was evaluated for recent onset of severe headaches, unresponsive to analgesics and anti-migraine medications. MRI of the brain revealed hyper-intensities in the white matter in the frontal lobes. Serum IgA anti-β2GPI antibody titres were 29.1 Standard A Units (SAU). 3) Thirty-two-year-old Hispanic female with history of two unexplained miscarriages and negative serologies for SLE. Serum IgA anti-β2GPI antibody titres were 102.0 SAU. 4) Twenty-five-year-old white female with history of recent unexplained miscarriage in the 11th week of gestation and associated complaints of numbness and tingling in her hands. Her IgA anti-β2GPI antibody titre was 62.0 SAU. 5) Twenty-five-year-old African-American woman with SLE, positive for anti-Ro antibodies with a history of ischemic fingers, a pregnancy loss and recent pregnancy complicated due to pre-eclampsia. Her LA was positive and her IgA anti-β2 GPI antibody titer was 186.0 SAU. This case series supports that elevated IgA anti-β2GPI antibody titres may identify additional patients who have clinical features of APS but who do not meet current diagnostic criteria.",
keywords = "Antiphospholipid antibodies, Antiphospholipid syndrome, IgA anti-β2glycoprotein I antibodies",
author = "S. Kumar and E. Papalardo and P. Sunkureddi and S. Najam and Emilio Gonzalez and Pierangeli, {S. S.}",
year = "2009",
doi = "10.1177/0961203309103048",
language = "English (US)",
volume = "18",
pages = "1011--1014",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "11",

}

TY - JOUR

T1 - Isolated elevation of IgA anti-β2glycoprotein I antibodies with manifestations of antiphospholipid syndrome

T2 - A case series of five patients

AU - Kumar, S.

AU - Papalardo, E.

AU - Sunkureddi, P.

AU - Najam, S.

AU - Gonzalez, Emilio

AU - Pierangeli, S. S.

PY - 2009

Y1 - 2009

N2 - Current diagnostic classification criteria recommend elevated titres of anti-cardiolipin (aCL) and/or anti-β2GPI antibody by ELISA IgG or IgM and/or lupus anticoagulant (LA) to confirm antiphospholipid syndrome (APS). Although IgA aPL antibodies have been shown to be pathogenic in animal models of APS, their clinical significance has remained elusive. We report four cases of exclusive IgA anti-β2GPI antibody sero-positivity with concomitant clinical manifestations associated with APS. Four of the five patients were LA negative. 1) Thirty-eight-year-old African-American female with SLE presented with resolving digital ulcers. Serum IgA anti-β2GPI antibody titres were 118.5 SAU (normal range: 0-20 SAU). 2) Twenty-seven-year-old African-American woman with SLE was evaluated for recent onset of severe headaches, unresponsive to analgesics and anti-migraine medications. MRI of the brain revealed hyper-intensities in the white matter in the frontal lobes. Serum IgA anti-β2GPI antibody titres were 29.1 Standard A Units (SAU). 3) Thirty-two-year-old Hispanic female with history of two unexplained miscarriages and negative serologies for SLE. Serum IgA anti-β2GPI antibody titres were 102.0 SAU. 4) Twenty-five-year-old white female with history of recent unexplained miscarriage in the 11th week of gestation and associated complaints of numbness and tingling in her hands. Her IgA anti-β2GPI antibody titre was 62.0 SAU. 5) Twenty-five-year-old African-American woman with SLE, positive for anti-Ro antibodies with a history of ischemic fingers, a pregnancy loss and recent pregnancy complicated due to pre-eclampsia. Her LA was positive and her IgA anti-β2 GPI antibody titer was 186.0 SAU. This case series supports that elevated IgA anti-β2GPI antibody titres may identify additional patients who have clinical features of APS but who do not meet current diagnostic criteria.

AB - Current diagnostic classification criteria recommend elevated titres of anti-cardiolipin (aCL) and/or anti-β2GPI antibody by ELISA IgG or IgM and/or lupus anticoagulant (LA) to confirm antiphospholipid syndrome (APS). Although IgA aPL antibodies have been shown to be pathogenic in animal models of APS, their clinical significance has remained elusive. We report four cases of exclusive IgA anti-β2GPI antibody sero-positivity with concomitant clinical manifestations associated with APS. Four of the five patients were LA negative. 1) Thirty-eight-year-old African-American female with SLE presented with resolving digital ulcers. Serum IgA anti-β2GPI antibody titres were 118.5 SAU (normal range: 0-20 SAU). 2) Twenty-seven-year-old African-American woman with SLE was evaluated for recent onset of severe headaches, unresponsive to analgesics and anti-migraine medications. MRI of the brain revealed hyper-intensities in the white matter in the frontal lobes. Serum IgA anti-β2GPI antibody titres were 29.1 Standard A Units (SAU). 3) Thirty-two-year-old Hispanic female with history of two unexplained miscarriages and negative serologies for SLE. Serum IgA anti-β2GPI antibody titres were 102.0 SAU. 4) Twenty-five-year-old white female with history of recent unexplained miscarriage in the 11th week of gestation and associated complaints of numbness and tingling in her hands. Her IgA anti-β2GPI antibody titre was 62.0 SAU. 5) Twenty-five-year-old African-American woman with SLE, positive for anti-Ro antibodies with a history of ischemic fingers, a pregnancy loss and recent pregnancy complicated due to pre-eclampsia. Her LA was positive and her IgA anti-β2 GPI antibody titer was 186.0 SAU. This case series supports that elevated IgA anti-β2GPI antibody titres may identify additional patients who have clinical features of APS but who do not meet current diagnostic criteria.

KW - Antiphospholipid antibodies

KW - Antiphospholipid syndrome

KW - IgA anti-β2glycoprotein I antibodies

UR - http://www.scopus.com/inward/record.url?scp=70349512004&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349512004&partnerID=8YFLogxK

U2 - 10.1177/0961203309103048

DO - 10.1177/0961203309103048

M3 - Article

VL - 18

SP - 1011

EP - 1014

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 11

ER -